India emerges as world-class cost-effective healthcare destination, global pharma leader: Jitin Prasada

Written By : Ruchika Sharma Published On 2024-08-29T13:00:55+05:30 | Updated On 29 Aug 2024 1:01 PM IST

The Minister urged the industry to focus on innovation, quality and work with the world market.

New Delhi: Union Minister of State for Commerce & Industry Shri Jitin Prasada said that India has emerged as a world-class cost-effective healthcare destination and global pharma leader. The Minister stated this while inaugurating the three day International Exhibition For Pharma And Healthcare Exhibition (IPHEX 2024) organised by Pharma Export Promotion Council of India (CAPEXIL) and Ministry of Commerce and Industry at Greater Noida, Uttar Pradesh. He urged the Indian Pharmaceutical industry to work towards becoming the healthcare custodian of the world.

He urged the pharma industry to increase exports and seize emerging opportunities for growth. Shri Prasada said that India is already recognized as the 'pharmacy of the world'. It's extremely important that we focus not only on our strengths in the generic sector, but also ensure our backward and forward linkages, the Minister added. He further noted that its important that we try product development and break new grounds.

The Minister urged the industry to focus on innovation, quality and work with the world market. "International competitiveness will be very important. It is important to keep abreast of new developments and good manufacturing practices”, he said. He also noted that the Government has come up with many schemes like the PLI for APIs and for medical devices.

Also Read:Sun Pharmaceutical Industry gets CDSCO Panel nod to study Fexuprazan HCL tablet for erosive esophagitis

Shri Prasada said, “The three day pharma expo IPHEX will offer the domestic industry majors from India and all across the world a great platform to connect and do business. It will provide you with an opportunity to meet new and existing customers actively looking for new suppliers, or looking to assess the current progress of existing projects.”

Also Read:Intas Pharmaceuticals Gets CDSCO Panel Nod to Study Vedolizumab for Ulcerative Colitis

jitin prasadainternational exhibition for pharma and healthcare exhibitionIPHEX 2024pharma export promotion council of indiaCAPEXILmedical device

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751